Background Beta-synuclein is an emerging blood biomarker for detecting synaptic damage in Alzheimer’s disease (AD) but its role in early AD as well as in other dementias is unclear. Methods We ...

There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...

Gout patients who met a target serum urate level of < 360 μmol/L (6 mg/dL) within 12 months of treatment cut their risk for major cardiovascular events vs patients who did not.